Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection

Experimental and Molecular Pathology

Volumn 100, Issue 1, 2016, Pages 45-50

  Cai, Junchao ^a   Terasaki, Paul I ^a   Zhu, Dong ^b   Lachmann, Nils ^c   Schönemann, Constanze ^c   Everly, Matthew J ^a   Qing, Xin ^d  

^a Terasaki Foundation   (United States)

^b FUDAN UNIVERSITY   (China)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Antibody epitope; Antibody mediated rejection; c1q fixing antibody; Denatured antigen; HLA antibody; MICA antibody; Renal transplant

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT FIXING ANTIBODY; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ANTIBODY; COMPLEMENT COMPONENT C1Q; HLA ANTIGEN CLASS 1; MHC CLASS I-RELATED CHAIN A;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURVIVAL RATE; AGED; ALLOTRANSPLANTATION; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; PROCEDURES;

ADULT; AGED; ANTIBODIES; COMPLEMENT C1Q; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84949580233     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.11.023     Document Type: Article

References (35)

1. Alberu J., et al. A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. Transpl. Immunol. 2007, 18(2):166-171.
2. Burlingham W.J., Claas F.H. Soluble MHC in allograft recipients. Hum. Immunol. 1999, 60(5):401-402.
3. Cai J., Terasaki P.I. Humoral theory of transplantation: mechanism, prevention, and treatment. Hum. Immunol. 2005, 66(4):334-342.
4. Cai J., Terasaki P.I. Human leukocyte antigen antibodies for monitoring transplant patients. Surg. Today 2005, 35(8):605-612.
5. Cai J., Terasaki P.I. Post-transplantation antibody monitoring and HLA antibody epitope identification. Curr. Opin. Immunol. 2008, 20(5):602-606.
6. Cai J., et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am. J. Transplant. 2006, 6(12):2947-2954.
7. Cai J., Kohanof S., Terasaki P.I. HLA-DR antibody epitopes. Clin. Transpl. 2006, 103-114.
8. Cai J., et al. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009, 88(2):226-230.
9. Cai J., et al. Humoral theory of transplantation: some hot topics. Br. Med. Bull. 2013, 105:139-155.
10. Chin C., et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J. Heart Lung Transplant 2011, 30(2):158-163.
11. Cook D.J., et al. The flow cytometry crossmatch in kidney transplantation. Clin. Transpl. 1987, 409-414.
12. DeVito-Haynes L.D., et al. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum. Immunol. 1994, 40(3):191-201.
13. DeVito-Haynes L.D., et al. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection. Hum. Immunol. 1998, 59(7):426-434.
14. El-Awar N., Cook D., Terasaki P.I. HLA class I epitopes: A and B loci. Clin. Transpl. 2006, 79-94.
15. El-Awar N., et al. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin. Transpl. 2007, 175-194.
16. El-Awar N., et al. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens. Clin. Transpl. 2009, 295-321.
17. Erickson R.H., Kim Y.S. Digestion and absorption of dietary protein. Annu. Rev. Med. 1990, 41:133-139.
18. Lachmann N., et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009, 87(10):1505-1513.
19. Lee P.C., et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002, 74(8):1192-1194.
20. Morales-Buenrostro L.E., et al. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008, 86(8):1111-1115.
21. Ozawa M., et al. 14th international HLA and immunogenetics workshop: report on the prospective chronic rejection project. Tissue Antigens 2007, 69(Suppl. 1):174-179.
22. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N. Engl. J. Med. 1969, 280(14):735-739.
23. Pei R., et al. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum. Immunol. 1999, 60(12):1293-1302.
24. Pei R., et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003, 75(1):43-49.
25. Piazza A., et al. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival. Clin. Transpl. 2013, 367-375.
26. Roberts P.R., et al. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 1999, 60(4):332-337.
27. Sell K.W., et al. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation. J. Heart Transplant 1988, 7(6):407-418.
28. Terasaki P.I. Humoral theory of transplantation. Am. J. Transplant. 2003, 3(6):665-673.
29. Terasaki P.I., Cai J. Humoral theory of transplantation: further evidence. Curr. Opin. Immunol. 2005, 17(5):541-545.
30. Terasaki P.I., Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008, 86(3):377-383.
31. Terasaki P.I., McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 1964, 204:998-1000.
32. Terasaki P.I., Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am. J. Transplant. 2004, 4(3):438-443.
33. Terasaki P.I., Rich N.E. Quantitative determination of antibody and complement directed against lymphocytes. J. Immunol. 1964, 92:128-138.
34. Wang Y.C., et al. Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro. Hum. Immunol. 1991, 31(2):123-133.
35. Yabu J.M., et al. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011, 91(3):342-347.